[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368903-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368903-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-insights-into-proliferation-and-inflammation-in-actinic-keratosis-and-photodynamic-therapy-a-comprehensive-review-of-proliferation-and-inflammation-markers","Molecular insights into proliferation and inflammation in actinic keratosis and photodynamic therapy - a comprehensive review of proliferation and inflammation markers","","Actinic keratosis (AK) is a common precancerous lesion capable of progressing to cutaneous squamous cell carcinoma, making molecular risk stratification clinically valuable. This review synthesizes evidence on biomarkers of proliferation and inflammation—Ki-67, p53, MMPs, COX-2, and MCM2—and their relationship to AK progression and response to photodynamic therapy. Ki-67 and MMPs may support monitoring, while COX-2 prognostic value remains unclear and MCM2 warrants further study for cSCC transition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-insights-into-proliferation-and-inflammation-in-actinic-keratosis-and-photodynamic-therapy-a-comprehensive-review-of-proliferation-and-inflammation-markers/368903/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-insights-into-proliferation-and-inflammation-in-actinic-keratosis-and-photodynamic-therapy-a-comprehensive-review-of-proliferation-and-inflammation-markers/368903.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the role of Ki-67 in actinic keratosis and treatment monitoring?","Question",{"text":63,"@type":64},"Ki-67 is a proliferation marker linked to tumor growth and shows elevated immunoexpression in AK. After successful AK treatment, Ki-67 can decline, supporting its use as a therapeutic indicator.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do p53 mutations relate to AK progression?",{"text":68,"@type":64},"p53 mutations are common in AK and are associated with disease progression. Persistence of mutant-cell populations after treatment suggests the potential need for multiple therapy sessions.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biomarkers reflect inflammation in AK, and what is known about COX-2?",{"text":72,"@type":64},"COX-2 is associated with inflammation and is upregulated in AK. Its prognostic significance remains uncertain, requiring additional research before it can be fully integrated into clinical decision-making.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368903,1790320409,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Actinic keratosis (AK) is a common precancerous skin lesion with the potential to progress into cutaneoussquamous cell carcinoma (cSCC) . Understanding molecular markers involved in AK pathogenesis can aid in assessing disease severity, monitoring treatment response, and identifying patients at risk of malignant transformation. This review examines key biomarkers, including Ki-67, p53, matrix metalloproteinases (MMPs), cyclooxygenase-2 (COX-2), and minichromosome maintenance protein 2 (MCM2), focusing on their role in AK progression and response to photodynamic therapy. Ki-67, a proliferation marker, declines following successful AK treatment, making it a useful therapeutic indicator. p53 mutations, common in AK, are linked to disease progression, but post-treatment persistence of mutant cells suggests the need for multiple therapy sessions. MMP-1 and MMP-2 contribute to extracellular matrix remodeling and may serve as markers of treatment efficacy. COX-2, associated with inflammation, is upregulated in AK, but its prognostic significance remains uncertain. MCM2 expression correlates with AK severity and proliferation, yet its role in cSCC progression requires further investigation. These findings highlight the importance of molecular biomarkers in AK diagnosis and treatment monitoring, suggesting that while Ki-67 and MMPs may be valuable therapeutic markers, additional research is needed to fully integrate these biomarkers into clinical practice.  \nKey words: p53, Ki-67, photodynamic therapy, actinic keratosis, MMPs, MCM2, COX-2 .  \nContemp Oncol (Pozn) 2025; 29 (3): 232–239 DOI: [https://doi.org/10.5114/wo.2025.153843](https://doi.org/10.5114/wo.2025.153843)  \nReview paper  \nMolecular insights into proliferation and inflammation in actinic keratosis and photodynamic therapy: a comprehensive review of proliferation and inflammation markers  \nJustyna Ceryn, Aleksandra Lesiak, Magdalena Ciążyńska, Joanna Narbutt  \nDepartment of Dermatology, Pediatric Dermatology and Oncology Clinic, Medical University of Lodz, Poland  \nIntroduction  \nActinic keratosis (AK) is a common intraepidermal dysplasia with potential for progression to cutaneous squamous cell carcinoma (cSCC) . The condition affects about 25% of adults, with prevalence rising from 4.6% in those aged 60–69 to 14. 57% in individuals over 80 [1] . Clinically, AK presents with hyperkeratosis and erythema, primarily on chronically sun-exposed areas, with ultraviolet (UV) radiation being the key etiological factor [2, 3] . The annual risk of AK evolving into invasive squamous cell carcinoma (iSCC) ranges from 0. 025% to 16%[4] . Features such as induration, bleeding, pain, and increased lesion size suggest malignant transformation [5] . AK is also linked to field cancerization (FC), a phenomenon characterized by genetically altered subclinical changes surrounding visible lesions, predisposing to malignancy [6] . Molecular studies implicate oncogenic and tumor suppressor gene dysregulation in AK and non-melanoma skin cancers (NMSCs) . Increasing attention has been directed toward signal transduction pathways involved in AK pathogenesis. This review explores key proliferation markers (Ki-67, p53, matrix metalloproteinases [MMPs]) and inflammation markers (cyclooxygenase-2 [COX-2], minichromosome maintenance protein 2 [MCM2]) in AK. Particular attention is given to their potential utility in monitoring AK treatment, particularly with photodynamic therapy (PDT) . A summary of the relevant studies is provided in Table 1.  \nKi-67  \nKi-67 is a key proliferation marker essential for DNA replication, expressed in all cell cycle phases except G0 . It is normally found in the basal epidermal layer and is strongly linked to tumor growth. Its increased expression in sun-damaged skin and FC indicates a high proliferative capacity in AK [7] .  \nStudies confirm elevated Ki-67 immunoexpression in AK lesions. Khoadeini et al. [8] reported widespread Ki-67 and p53 immunopositivity in malignant e","cbCaimATerbkrFrq","https://ap.wps.com/l/cbCaimATerbkrFrq","pdf",89767,"English","# Introduction\n# Ki-67\n## Ki-67 immunoexpression in actinic keratosis and field cancerization\n# Biomarkers and photodynamic therapy (PDT)\n## p53, MMPs, COX-2, and MCM2","[{\"question\":\"What is the role of Ki-67 in actinic keratosis and treatment monitoring?\",\"answer\":\"Ki-67 is a proliferation marker linked to tumor growth and shows elevated immunoexpression in AK. After successful AK treatment, Ki-67 can decline, supporting its use as a therapeutic indicator.\"},{\"question\":\"How do p53 mutations relate to AK progression?\",\"answer\":\"p53 mutations are common in AK and are associated with disease progression. Persistence of mutant-cell populations after treatment suggests the potential need for multiple therapy sessions.\"},{\"question\":\"Which biomarkers reflect inflammation in AK, and what is known about COX-2?\",\"answer\":\"COX-2 is associated with inflammation and is upregulated in AK. Its prognostic significance remains uncertain, requiring additional research before it can be fully integrated into clinical decision-making.\"}]","Molecular insights into proliferation and inflammation in actinic keratosis and photodynamic therapy - a comprehensive review of proliferation and inflammation markers | PDF",1790179140,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6abab85891f1525ca465d0938a7e4ae0.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b8965b40d5cb4e59120bb9511d4e1e1.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46b7b8e95180706a5c88fd5e6cc3f3be.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9aeaf937447c11935fb933fe330e4653.webp",980,1385]